Pfizer Ups Stock Buyback to $10 Billion
Wikimedia CommonsIn a sign that Pfizer Inc. (NYSE: PFE) has more cash on hand than the sense to use it wisely to create new drugs, its board approved a $10 billion share buyback. Pfizer has effectively cut costs, some via…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
In a sign that Pfizer Inc. (NYSE: PFE) has more cash on hand than the sense to use it wisely to create new drugs, its board approved a $10 billion share buyback. Pfizer has effectively cut costs, some via layoffs. R&D on new treatments is critical to the pharma company in a world of new age medicines, biotech and generics. Nonetheless, Pfizer believes it can increase shareholder returns by delivering cash the way that other public corporations like McDonald’s Corp. (NYSE: MCD) do. But a pharma company is not a fast-food chain.
The company announced:
The board of directors of Pfizer Inc. today declared a 24-cent third-quarter 2013 dividend on the company’s common stock, payable September 4, 2013, to shareholders of record at the close of business on August 2, 2013. The third-quarter 2013 cash dividend will be the 299th consecutive quarterly dividend paid by Pfizer.
In addition, the board of directors has authorized a new $10 billion share repurchase program to be utilized over time. This new program is in addition to the $3.9 billion of authorization remaining under the company’s current share repurchase program.
Contact [email protected] for any questions or corrections.
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.
